deamination of catecholamines was powerfully and dose-dependently inhibited by moclobemide , as evidenced by up to 40 % decreases in the urinary excretion of deaminated catecholamine metabolites , corresponding increases in the excretion of non-deaminated , methylated metabolites , and up to 79 % average decreases in the plasma concentration of 3,4-dihydroxyphenylglycol ( dhpg ) , a deaminated metabolite of noradrenaline ( na ) , and up to 75 % average decreases in the plasma concentrations of 3,4-dihydroxyphenylacetic acid ( dopac ) , a deaminated metabolite of dopamine .
C0007412
catecholamines
C0013030
dopamine